This study highlights the role of Type II cGMP-dependent protein kinase (PKG II) in inhibiting EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in GC cells (Wu et al., 2012). The gene discussed is EGF; the disease is gastric cancer.